Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Rocuronium

    Client Email Product

    Rocuronium

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    GLOBAL SALES INFORMATION

    MARKET PLACE

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    36
    US DMFs Filed

    US DMFs Filed

    12
    CEP/COS Certifications

    CEP/COS Certifications

    8
    JDMFs Filed

    JDMFs Filed

    3
    Other Certificates

    Other Certificates

    2
    Other Suppliers

    Other Suppliers

    29
    API REF. PRICE (USD / KG)
    18,450

    API Market Place

    16
    INTERMEDIATES
    18
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    32
    Europe

    Europe

    19
    Canada

    Canada

    5
    Australia

    Australia

    0

    South Africa

    South Africa

    11
    Uploaded Dossiers

    Uploaded Dossiers

    19
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    0

    FDF Market Place

    17
    EXCIPIENTS
    2
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    1

    News

    25
    REF STANDARD

    EDQM

    2

    USP

    2

    JP

    0

    Other Listed Suppliers

    12
    SERVICES

    0

    left grey arrow
    right gray arrow
    • INJECTABLE;INJECTION - 100MG/10ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • INJECTABLE;INJECTION - 10MG/ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • INJECTABLE;INJECTION - 50MG/5ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    Full View ScreenFull Screen View
    Enforcement Report - Week of September 6, 2023
    Enforcement Report - Week of September 6, 2023

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-6-2023-36272.pdf

    FDA
    06 Sep 2023
    Share Share
    Enforcement Report - Week of August 9, 2023
    Enforcement Report - Week of August 9, 2023

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-9-2023-9584.pdf

    FDA
    09 Aug 2023
    Share Share
    GENIXUS Announces Launch of KinetiXTM Rocuronium Bromide Injection
    GENIXUS Announces Launch of KinetiXTM Rocuronium Bromide Injection

    https://www.businesswire.com/news/home/20230803139911/en

    BUSINESSWIRE
    03 Aug 2023
    Share Share
    Fresenius Kabi Launches RFID-Enabled Rocuronium Bromide Injection
    Fresenius Kabi Launches RFID-Enabled Rocuronium Bromide Injection

    https://www.businesswire.com/news/home/20230530005081/en

    BUSINESSWIRE
    30 May 2023
    Share Share
    Hong Kong's Generic Rocuronium Bromide Receives Receives Approval in the U.S.
    Hong Kong's Generic Rocuronium Bromide Receives Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213453

    FDA
    08 May 2023
    Share Share
    Enforcement Report - Week of January 18, 2023
    Enforcement Report - Week of January 18, 2023

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-18-2023-33998.pdf

    FDA
    18 Jan 2023
    Share Share
    Piramal Critical Care Launches First to Market Generic Zinc Sulfate Injection in the U.S.
    Piramal Critical Care Launches First to Market Generic Zinc Sulfate Injection in the U.S.

    https://www.prnewswire.com/news-releases/piramal-critical-care-launches-first-to-market-generic-zinc-sulfate-injection-in-the-us-301608664.html

    PRNEWSWIRE
    19 Aug 2022
    Share Share
    Enforcement Report - Week of June 8, 2022
    Enforcement Report - Week of June 8, 2022

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-8-2022-1654674832.pdf

    FDA
    08 Jun 2022
    Share Share
    Hameln has received certificate “Union Format for Registration of Manufacturer
    Hameln has received certificate “Union Format for Registration of Manufacturer

    https://www.hameln-rds.sk/news-2/

    PRESS RELEASE
    03 Jan 2022
    Share Share
    Enforcement Report- Week of October 27, 2021
    Enforcement Report- Week of October 27, 2021

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-27-2021-1635324993.pdf

    FDA
    27 Oct 2021
    Share Share
    Rocuronium bromide solution for injection 10mg/mL, Hameln, and reports of lack
    Rocuronium bromide solution for injection 10mg/mL, Hameln, and reports of lack

    https://medsafe.govt.nz/safety/Alerts/Rocuronium.asp

    GOVT
    31 Jul 2020
    Share Share
    Wavelength Ups API Production for Essential Respiratory Meds
    Wavelength Ups API Production for Essential Respiratory Meds

    https://www.contractpharma.com/contents/view_breaking-news/2020-04-20/wavelength-ups-api-production-for-essential-respiratory-meds/

    CONTRACTPHARMA
    20 Apr 2020
    Share Share
    Wavelength Expands Supplies of Key Drug Ingredients for Critically Ill COVID-19
    Wavelength Expands Supplies of Key Drug Ingredients for Critically Ill COVID-19

    https://www.biospace.com/article/releases/wavelength-pharmaceuticals-expands-supplies-of-key-drug-ingredients-for-critically-ill-covid-19-patients/

    BIOSPACE
    20 Apr 2020
    Share Share
    Camargo Pharma's Generic Rocuronium Bromide Receives Approval in US
    Camargo Pharma's Generic Rocuronium Bromide Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210437

    FDA
    19 Aug 2019
    Share Share
    Medicines Safety Update, Volume 9, Number 3, August-September 2018
    Medicines Safety Update, Volume 9, Number 3, August-September 2018

    https://www.tga.gov.au/publication-issue/medicines-safety-update-volume-9-number-3-august-september-2018

    TGA
    17 Sep 2018
    Share Share
    Gland Chem`s Generic Rocuronium Bromide Receives Approval In US
    Gland Chem`s Generic Rocuronium Bromide Receives Approval In US

    https://www.pharmacompass.com/pdf/news/gland-chem-s-generic-rocuronium-bromide-receives-approval-in-us-1522993094.pdf

    FDA
    06 Apr 2018
    Share Share
    FDA Issues Form 483 to SCA Pharmaceuticals (Outsourcing Facility)
    FDA Issues Form 483 to SCA Pharmaceuticals (Outsourcing Facility)

    https://www.pharmacompass.com/pdf/news/fda-issues-form-483-to-sca-pharmaceuticals-outsourcing-facility-1522487914.pdf

    FDA
    29 Mar 2018
    Share Share
    Enforcement Report - Week of February 28, 2018
    Enforcement Report - Week of February 28, 2018

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-28-2018-1519803579.pdf

    FDA
    28 Feb 2018
    Share Share
    Enforcement Report - Week of November 8, 2017
    Enforcement Report - Week of November 8, 2017

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-8-2017-1510120910.pdf

    FDA
    08 Nov 2017
    Share Share
    SCA Pharmaceuticals Issues Voluntary Nationwide Recall of Specific Products
    SCA Pharmaceuticals Issues Voluntary Nationwide Recall of Specific Products

    https://www.pharmacompass.com/pdf/news/SCA-Pharmaceuticals-Issues-Voluntary-Nationwide-Recall-of-Specific-Products-1508760244.pdf

    FDA
    21 Oct 2017
    Share Share
    Enforcement Report - Week of August 16, 2017
    Enforcement Report - Week of August 16, 2017

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-16-2017-1502850779.pdf

    FDA
    16 Aug 2017
    Share Share
    West Ward Pharm’s Generic Rocuronium Bromide Receives Approval In US
    West Ward Pharm’s Generic Rocuronium Bromide Receives Approval In US

    http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204679

    FDA
    02 Mar 2017
    Share Share
    Gland Chemicals Receives Written Confirmation of Export of 3 APIs to EU
    Gland Chemicals Receives Written Confirmation of Export of 3 APIs to EU

    http://twofourinsight.com/gland-chemicals-receives-written-confirmation-export-apis-eu/

    TWOFOUR INSIGHT
    20 Jan 2016
    Share Share
    At long last, Merck gets FDA panel backing for Bridion
    At long last, Merck gets FDA panel backing for Bridion

    http://www.pmlive.com/pharma_news/at_long_last,_merck_gets_fda_panel_backing_for_bridion_862140

    Phil Taylor PM LIVE
    10 Nov 2015
    Share Share
    Dutch pension fund pulls out of Mylan amid death penalty drug concerns
    Dutch pension fund pulls out of Mylan amid death penalty drug concerns

    http://www.fiercepharma.com/story/dutch-pension-fund-pulls-out-mylan-amid-death-penalty-drug-concerns/2015-08-31

    Emily Wasserman FIERCE PHARMA
    31 Aug 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    Synnat Rocuronium Bromide

    Access Virtual Booth

    Contact Supplier

    View Presentation

    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search